Long COVID-19 and MAB Study

NCT ID: NCT05508295

Last Updated: 2023-06-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

300 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-06-20

Study Completion Date

2024-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will be observational only. It will provide real-world evidence generated from a representative and large-scale COVID patient base. The adoption, pilot testing and use of NIH PROs among viral tested patients with research purpose on long COVID will be unique and innovative. With the existing and proven scientific rigor, NIH PRO system will be adopted, then modified and tailored to form the long hauler specific, comprehensive instrument, helping generalize future knowledge regarding COVID-infected patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

COVID-19

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

COVID positive case with mAb treatment

No interventions assigned to this group

COVID positive case having not received mAb treatment

No interventions assigned to this group

COVID negative cases

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Have been tested for COVID at one of the MultiCare facilities,
* AND 18 years old or older at the viral test,
* AND have no problem understanding English or Spanish.

Exclusion Criteria

* Pediatric patients younger than 18 years old at the time of testing,
* OR patients who are pregnant,
* OR patients who plan to get pregnant in 3 months,
* OR patients who are hospitalized at the time of recruitment,
* OR patients who have cognitive impairment(s) at the recruitment.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

MultiCare Health System Research Institute

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

MultiCare Health System

Tacoma, Washington, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Hollis Zeng

Role: CONTACT

2534037250

Jin Mou

Role: CONTACT

2534037250

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Jin Mou, MD, MSc, MPH, Ph.D

Role: primary

253.403.7250

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

02/01/2022

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Multimodal Long Covid19
NCT05932797 UNKNOWN NA
The Canadian COVID-19 Prospective Cohort Study
NCT05125510 ACTIVE_NOT_RECRUITING